Compare First Citizens BancShares Inc (FCNCA) vs Regeneron Pharmaceuticals Inc (REGN) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
First Citizens BancShares Inc vs Regeneron Pharmaceuticals Inc — how do they compare? First Citizens BancShares Inc trades at $2,249.28 (market cap $25.04B), while Regeneron Pharmaceuticals Inc trades at $796.38 (market cap $82.06B). The key difference: Regeneron Pharmaceuticals Inc is far larger — about 3.3× First Citizens BancShares Inc's market cap, and Regeneron Pharmaceuticals Inc pays the higher dividend (0.47%). Which is the better fit depends on your goals.
| FCNCA | REGN | |
|---|---|---|
Market Cap | $25.04B | $82.06B |
Sector | Sector/Thematic | Health |
52-Week High | $2.25K | $812.27 |
52-Week Low | $1.64K | $555.51 |
Dividend Yield | 0.37% | 0.47% |
Enterprise Value | — | $76.77B |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About First Citizens BancShares Inc
First Citizens BancShares is a major US regional bank providing diverse financial services. It recently expanded significantly by acquiring the assets and liabilities of Silicon Valley Bank.
Read more on FCNCA →About Regeneron Pharmaceuticals Inc
Regeneron Pharmaceuticals discovers, develops, and commercializes products that fight eye disease, cardiovascular disease, cancer, and inflammation. The company has several marketed products, including Eylea, approved for wet age-related macular degeneration and other eye diseases
Read more on REGN →
